A Phase I Study on the Pharmacokinetics and Pharmacodynamics of DJT1116PG, a Novel Selective Inhibitor of Sodium-glucose Cotransporter Type 2, in Healthy Individuals at Steady State
- Resource Type
- Article
- Source
- In
Clinical Therapeutics May 2020 42(5):892-905 - Subject
- Language
- ISSN
- 0149-2918